Glenmark Pharmaceuticals Limited
NSE: GLENMARKINE935A01035·HealthcareMidcap 150·www.glenmarkpharma.com ↗·Mcap ₹69,769 Cr·Listed 2000
₹2,380.00▼ ₹50.40  (−2.07%)
52W: ₹1,793 – ₹2,538 · Vol: 7.9L shares · Close 25 Sept
Set Alert
OverviewFinancialsChartsWavesScreenersThesisNewsPeers

My Thesis

your own words · only you can see them
AI investment thesis — coming soon
Broker targets — coming soon
Dates Ahead
14 Nov
2026
Results for the quarter ending Sept 2026 due by this date
45 days from the quarter's end (SEBI listing rules); the company names the actual day
Thesis integrity score — coming soon
Analyst buy/hold/sell — coming soon